Press release
Leading Companies Advancing Innovation and Growth in the Male Infertility Market
Male Infertility
Projected Growth Trajectory of the Male Infertility Market by 2029
The male infertility market is projected to experience substantial growth, reaching a value of $4.63 billion by 2029, with a compound annual growth rate (CAGR) of 5.2%. This expansion is fueled by heightened attention to genetic and epigenetic factors, the rising popularity of personalized infertility therapies, increased medical tourism for fertility services, innovations in sperm retrieval and preservation techniques, and the growing adoption of telehealth for fertility consultations. Key trends expected to influence market dynamics include the widespread use of genetic testing for infertility diagnosis, advancements in sperm retrieval methods such as micro-TESE, a surge in demand for non-invasive fertility treatments, the introduction of tailored male fertility treatment plans, and the expanding use of stem cell therapies aimed at restoring spermatogenesis.
Download a free sample of the male infertility market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp
Top Players Driving the Male Infertility Market
Several prominent organizations lead the male infertility market, including Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, and Shree IVF Clinics.
In a notable development in June 2024, CooperSurgical, a US-based fertility and women's health company, acquired ZyMot Fertility. This acquisition enhances CooperSurgical's assisted reproductive technology (ART) portfolio by incorporating a patented sperm separation device designed to improve motile sperm selection and pregnancy success rates. ZyMot Fertility specializes in advanced sperm separation technology for male infertility treatment.
Strategic Collaborations Influencing the Male Infertility Market
Leading companies in the male infertility sector are increasingly engaging in strategic partnerships to widen access to innovative fertility treatments worldwide. Such collaborations combine expertise and resources to foster innovation, expand market reach, and boost research and development. For example, in June 2024, Ferring Pharmaceuticals, headquartered in Switzerland, teamed up with Posterity Health, a US-based male fertility clinic. Together, they launched a male fertility program on Ferring's Fertility Out Loud platform aimed at educating men about their reproductive health. This initiative provides men with confidential online fertility assessments and educational content developed by reproductive urologists, helping reduce the stigma associated with male infertility, which accounts for up to 50% of infertility cases. The program encourages early action through digital tools and telehealth, potentially improving outcomes for couples seeking parenthood.
View the full male infertility market report:
https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report
Key Segments of the Global Male Infertility Market Report
This report breaks down the male infertility market into several key segments:
1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology (ART)
2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, and other test types
3) By Distribution Channel: Hospital Pharmacies, Pharmacies and Drug Stores, Online Pharmacies
4) By End-User: Hospitals and Clinics, Fertility Centers, Research Institutes, and other end-users
Further subcategories include:
- Medication types such as Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, and Dopamine Agonists
- Surgical procedures including Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), and Sperm Retrieval Procedures
- Assisted Reproductive Technology methods like In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, and Cryopreservation of Sperm.
This segmentation offers a comprehensive framework to understand the diverse components and distribution channels shaping the male infertility market landscape.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Advancing Innovation and Growth in the Male Infertility Market here
News-ID: 4318689 • Views: …
More Releases from The Business Research Company
Leading Firms Fueling Growth and Innovation in the Pharmaceutical Pellets Market
The pharmaceutical pellets market is on track for substantial growth as innovations and evolving demands reshape the industry landscape. With advances in drug formulation and manufacturing techniques, this sector is set to expand significantly, driven by emerging needs across various patient demographics. Here's an in-depth look at the market's size, leading companies, key trends, and segment breakdowns.
Pharmaceutical Pellets Market Size and Projected Growth by 2029
The pharmaceutical pellets market…
An Overview of Segmentation, Market Dynamics, and Competitive Landscape in the P …
The proton pump inhibitors (PPIs) market is set for impressive growth as it continues to address the rising demand for effective treatment of acid-related disorders worldwide. With evolving healthcare trends and increasing awareness about gastrointestinal health, this sector is positioned to expand steadily over the next several years. Let's explore the market's size projections, influential players, emerging trends, and key segments shaping this dynamic landscape.
Projected Expansion of the Proton Pump…
Future Perspectives: Key Trends Shaping the Ophthalmic Drugs Market Until 2029
The ophthalmic drugs sector is positioned for significant expansion over the coming years, driven by key medical advancements and demographic factors. As eye-related health issues become more prevalent globally, the demand for innovative treatments is escalating, shaping the future outlook of this market. Let's explore the size, key players, trends, and segmentation dynamics of the ophthalmic drugs industry.
Future Growth Prospects and Market Size of the Ophthalmic Drugs Market
The…
Leading Companies Reinforcing Their Roles in the Pharmaceutical Supply Chain Man …
The pharmaceutical supply chain management sector is gearing up for substantial growth as advancements in technology and evolving industry needs reshape how medicines and healthcare products are delivered. This market is rapidly evolving with innovative solutions that enhance efficiency, security, and collaboration throughout the supply chain. Let's explore the current market size, influential companies, key trends, and segment-wise outlook shaping the pharmaceutical supply chain management industry.
Pharmaceutical Supply Chain Management Market…
More Releases for Male
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism refers to a medical condition in which the male body is unable to produce adequate levels of testosterone, the hormone responsible for the development and maintenance of male sexual characteristics. This condition can have a significant impact on a man's physical and emotional health, including reduced muscle mass, decreased bone density, and decreased
The male hypogonadism market encompasses the pharmaceuticals and therapies used to treat this condition. The…
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The Male Hypogonadism Market is an emerging segment in the medical industry. This condition affects millions of men around the world and can have serious implications for their physical and mental health. Treatment options are available to help manage symptoms, but often come with associated side effects. The Male Hypogonadism Market is expected to experience significant growth over the coming years as more therapies become available. Pharmaceutical companies are investing…
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The male hypogonadism market is a segment of the larger pharmaceutical industry that is focused on developing treatments for male hypogonadism, a condition in which the testes do not produce enough testosterone. In 2022, the male hypogonadism market is expected to continue to grow, driven by the increasing prevalence of the condition and the development of new treatments. The market is expected to be worth billions of dollars in 2022, with strong…
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism is a condition in which the body does not produce enough testosterone, the primary male sex hormone. This can lead to a variety of symptoms, including decreased, erectile dysfunction, fatigue, and muscle weakness. Male hypogonadism is typically treated with testosterone replacement therapy (TRT), which can be administered in several forms, such as gels, injections, and pellets.
Request For Free Sample Report of "Male Hypogonadism Market"@ https://www.persistencemarketresearch.com/samples/22303
The global male hypogonadism…
Male Origin Male Enhancement - Restore Testosterone, Best Reviews, Male Enhancem …
Male Origin Male Enhancement You need to go to your most unmistakable potential in the room, paying little mind to your age. Taking everything into account, you're a man. You ought to be OK at sex. Luckily, Male Origin Male Enhancement Male Enhancement can help with settling any sexual dysfunctions that are holding you down. For example, if you fight with unwinding when you undeniably shouldn't be limp, this can…
Libopro Male Enhance Review-Does Libopro Male Enhance Work-Complete Info
LiboPro Male Enhancement to an external site. Herbal is a herbal nutritional supplement that contains a effective mixture of the strongest natural ingredients that help you could Max out your performance. This supplement makes use of a natural composition as a way to assure you the safest results without Side Effects. This is the best quality manner right now to increase your sexual potential and revel in existence the way…
